Dimensional Fund Advisors
AVIR icon

Dimensional Fund Advisors’s Atea Pharmaceuticals AVIR Stock Holding History

Dimensional Fund Advisors’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.04M Buy
1,299,515
+44,031
+4% +$219K ﹤0.01% 2488
2026
Q1 		$6.75M Sell
1,255,484
-118,462
-9% -$544K ﹤0.01% 2399
2025
Q4 		$4.9M Sell
1,373,946
-166,770
-11% -$530K ﹤0.01% 2536
2025
Q3 		$4.47M Buy
1,540,716
+129,453
+9% +$442K ﹤0.01% 2578
2025
Q2 		$5.08M Buy
1,411,263
+227,537
+19% +$679K ﹤0.01% 2515
2025
Q1 		$3.54M Buy
1,183,726
+206,256
+21% +$644K ﹤0.01% 2597
2024
Q4 		$3.27M Buy
977,470
+183,844
+23% +$611K ﹤0.01% 2655
2024
Q3 		$2.66M Buy
793,626
+199,266
+34% +$723K ﹤0.01% 2713
2024
Q2 		$1.97M Buy
594,360
+211,428
+55% +$788K ﹤0.01% 2763
2024
Q1 		$1.55M Buy
382,932
+290,581
+315% +$1.14M ﹤0.01% 2841
2023
Q4 		$282K Hold
92,351
– – ﹤0.01% 3144
2023
Q3 		$277K Hold
92,351
– – ﹤0.01% 3154
2023
Q2 		$345K Buy
92,351
+30,712
+50% +$115K ﹤0.01% 3136
2023
Q1 		$206K Buy
+61,639
New +$250K ﹤0.01% 3193
2021
Q2 		– Sell
-3,683
Closed -$227K – 3461
2021
Q1 		$227K Buy
+3,683
New +$249K ﹤0.01% 3271

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors's AVIR Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Atea Pharmaceuticals (AVIR) stake by 3.5% in Q2 2026, buying an estimated $219K and bringing the position to 1,299,515 shares worth $6.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2488.

Dimensional Fund Advisors first reported a position in AVIR in Q1 2021 and has held it in 15 quarters since. The position peaked at $6.75M in Q1 2026. 125 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • Dimensional Fund Advisors held 1,299,515 shares of Atea Pharmaceuticals worth $6.04M as of Q2 2026.
  • Dimensional Fund Advisors bought 44,031 Atea Pharmaceuticals shares in Q2 2026, an estimated $219K.
  • Atea Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2488 holding.
  • Dimensional Fund Advisors first reported a position in Atea Pharmaceuticals in Q1 2021 and has held it in 15 quarters since.
  • Dimensional Fund Advisors's Atea Pharmaceuticals position peaked at $6.75M in Q1 2026.
  • 125 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.